Sylvia Oh, LCSW in Boise, ID - Social Worker

Sylvia Oh, LCSW is a Social Worker - Clinical based in Boise, Idaho. Sylvia Oh is licensed to practice in Idaho (license number LCSW38161) and her current practice location is 2118 S Latah St, Boise, Idaho. She can be reached at her office (for appointments etc.) via phone at (208) 999-7424.

NPI number for Sylvia Oh is 1013533231 and her current mailing address is 2118 S Latah St, Boise, Idaho. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1013533231.

Contact Information

	Sylvia Oh, LCSW
	2118 S Latah St, Boise, ID 83705-3947
	(208) 999-7424
	Not Available

Healthcare Provider's Profile

Full Name	Sylvia Oh
Gender	Female
Speciality	Social Worker - Clinical
Location	2118 S Latah St, Boise, Idaho
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1013533231
Provider Enumeration Date: 06/23/2020
Last Update Date: 05/09/2023

Medical Identifiers

Medical identifiers for Sylvia Oh such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1013533231	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1041C0700X	Social Worker - Clinical	15915 (California)	Secondary
1041C0700X	Social Worker - Clinical	LCSW38161 (Idaho)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Sylvia Oh is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Sylvia Oh, LCSW 2118 S Latah St, Boise, ID 83705-3947 Ph: (208) 999-7424	Sylvia Oh, LCSW 2118 S Latah St, Boise, ID 83705-3947 Ph: (208) 999-7424

News Archive

GlobalPost blog examines issue of HIV/AIDS in U.S. presidential election

GlobalPost's "Global Pulse" blog examines the issue of HIV/AIDS in the presidential election, writing, "This campaign season, the fight against HIV/AIDS has been absent from the press materials released by both President Barack Obama and Republican presidential nominee Gov. Mitt Romney - as well as from the conversation."

Immunomedics product candidates, technologies receive recognition from QTDP program

Immunomedics, Inc. a biopharmaceutical company primarily focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that all 12 applications from the Company were certified by the Internal Revenue Service of the Department of Treasury as qualified investments in accordance with the Qualifying Therapeutic Discovery Project (QTDP) program under section 48D of the Internal Revenue Code. As a result, the Company will receive an aggregate cash award of $2.9 million.

Annual diabetic retinopathy screening for children with type 1 diabetes should begin at later age, study says

A new study has found that the occurrence of advanced forms of a diabetic eye disease remains low among children living with diabetes, regardless of how long they have had the disease or their ability to keep blood sugar levels controlled. Researchers are therefore recommending that most children with type 1 diabetes delay annual diabetic retinopathy screenings until age 15, or 5 years after their diabetes diagnosis, whichever occurs later.

KHN's ‘What the Health?': All about Medicaid

Medicaid, the joint federal-state health program for people with low incomes, serves more than 70 million people, covers 1 in every 5 births in the U.S. and foots more than half the nation's bill for long-term care. Yet Medicaid isn't one program, it's 56 separate programs (one for each state plus the District of Columbia and U.S. territories).

United Therapeutics announces FDA approval of dinutuximab for treatment of high-risk neuroblastoma

United Therapeutics Corporation announced today that the United States Food and Drug Administration has approved Unituxin (dinutuximab) Injection (formerly called ch14.18), in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2), and 13-cis-retinoic acid (RA), for the treatment of pediatric patients with high-risk neuroblastoma who achieve at least a partial response to prior first-line multiagent, multimodality therapy.

Social Worker in Boise, ID

Mr. Johnny Josiah Meehan, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 6855 W Fairview Ave, Boise, ID 83704 Phone: 208-323-9600 Fax: 208-323-9606
Kristie Kaes, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1055 N Curtis Rd, Boise, ID 83706 Phone: 208-367-2121 Fax: 208-367-7305
John Bradford Hunt, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 202 N 9th St Ste 201c, Boise, ID 83702 Phone: 208-549-9597
Dr. Paula K Barrett, PSYD, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 444 W Fort St Fl 2, Boise, ID 83702 Phone: 208-422-1018
Rachel Jessen, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 5985 W State St, Boise, ID 83703 Phone: 208-853-0071 Fax: 208-853-9422
Mr. Tom C Ahlrichs, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 777 N Raymond St, Boise, ID 83704 Phone: 208-367-6044 Fax: 208-375-8817
Mrs. Amy Niblock Balzer, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1720 N Westgate Dr, Suite A-1, Boise, ID 83704 Phone: 208-334-0874 Fax: 208-334-0812

Sylvia Oh, LCSW - Clinical Social Worker in Boise, ID